Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 21266843)

1.

Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma.

Xie X, Koh JY, Price S, White E, Mehnert JM.

Cancer Discov. 2015 Apr;5(4):410-23. doi: 10.1158/2159-8290.CD-14-1473. Epub 2015 Feb 11.

PMID:
25673642
2.

Functional analysis of a novel glioma antigen, EFTUD1.

Saito K, Iizuka Y, Ohta S, Takahashi S, Nakamura K, Saya H, Yoshida K, Kawakami Y, Toda M.

Neuro Oncol. 2014 Dec;16(12):1618-29. doi: 10.1093/neuonc/nou132. Epub 2014 Jul 11.

PMID:
25015090
3.

Cytotoxic autophagy in cancer therapy.

Sharma K, Le N, Alotaibi M, Gewirtz DA.

Int J Mol Sci. 2014 Jun 5;15(6):10034-51. doi: 10.3390/ijms150610034. Review.

4.

Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor.

Bajer MM, Kunze MM, Blees JS, Bokesch HR, Chen H, Brauss TF, Dong Z, Gustafson KR, Biondi RM, Henrich CJ, McMahon JB, Colburn NH, Schmid T, Brüne B.

Biochem Pharmacol. 2014 Apr 1;88(3):313-21. doi: 10.1016/j.bcp.2014.01.034. Epub 2014 Feb 7.

5.

Glioblastoma multiforme therapy and mechanisms of resistance.

Ramirez YP, Weatherbee JL, Wheelhouse RT, Ross AH.

Pharmaceuticals (Basel). 2013 Nov 25;6(12):1475-506. doi: 10.3390/ph6121475.

6.

Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.

Lee SL, Chou CC, Chuang HC, Hsu EC, Chiu PC, Kulp SK, Byrd JC, Chen CS.

PLoS One. 2013 Jun 19;8(6):e67149. Print 2013.

7.

Coibamide A induces mTOR-independent autophagy and cell death in human glioblastoma cells.

Hau AM, Greenwood JA, Löhr CV, Serrill JD, Proteau PJ, Ganley IG, McPhail KL, Ishmael JE.

PLoS One. 2013 Jun 6;8(6):e65250. doi: 10.1371/journal.pone.0065250. Print 2013.

8.

The role of autophagy dysregulation in manganese-induced dopaminergic neurodegeneration.

Zhang J, Cao R, Cai T, Aschner M, Zhao F, Yao T, Chen Y, Cao Z, Luo W, Chen J.

Neurotox Res. 2013 Nov;24(4):478-90. doi: 10.1007/s12640-013-9392-5. Epub 2013 Apr 19. Erratum in: Neurotox Res. 2014 Aug;26(2):207-9.

9.

Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma.

Xie X, White EP, Mehnert JM.

PLoS One. 2013;8(1):e55096. doi: 10.1371/journal.pone.0055096. Epub 2013 Jan 30.

10.

Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy.

Surviladze Z, Sterk RT, DeHaro SA, Ozbun MA.

J Virol. 2013 Mar;87(5):2508-17. doi: 10.1128/JVI.02319-12. Epub 2012 Dec 19.

11.

Novel therapies in glioblastoma.

Perry J, Okamoto M, Guiou M, Shirai K, Errett A, Chakravarti A.

Neurol Res Int. 2012;2012:428565. doi: 10.1155/2012/428565. Epub 2012 Feb 28.

12.

Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death.

Gammoh N, Lam D, Puente C, Ganley I, Marks PA, Jiang X.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6561-5. doi: 10.1073/pnas.1204429109. Epub 2012 Apr 9.

13.

Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.

Taylor TE, Furnari FB, Cavenee WK.

Curr Cancer Drug Targets. 2012 Mar;12(3):197-209. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk